The BioFuture 2026 event in New York City promises to shape the future of biopharma with discussions on AI, innovation, and healthcare policies.

Be a part of the exciting healthcare and technology transformation! Register for BioFuture, a healthcare and technology conference in 2021.

Consumer research suggests that most consumers find Sun Bear Biofuture’s yeast-derived cocoa butter substitute equivalent to or better than the conventional fat. In a major validation of the burgeoning microbial fat industry, a majority of consumers were found unable to tell the difference between cocoa butter and a yeast-based alternative made by UK startup Sun Bear Biofuture. The research, carried out by the Centre for Nutrition and Health at Oxford Brookes University, revealed that the sustainable cocoa butter alternative was either equal to its conventional counterpart or the preferred purchase in four out of five products tested. In fact, participants could only identify the yeast fat in one of the five cases, which comprised three food innovations and two cosmetics products. Moreover, independent testing by the University of the Arts London’s (UAL) Cosmetics Science Department, backed by a grant from Innovate UK, found no difference in performance between the two fats in a hand balm formulation from a major high-street cosmetics brand. ‘This study set out to ask whether Sun Bear Biofutures cocoa butter alternative behaves as a direct, like-for-like swap for cocoa butter in this formulation,” said Joana Maia, a research scientist at UAL. “On the evidence gathered here,...

Demand for the oil has led to widespread deforestation. Now a company in Oxford has harnessed a ‘brewing process’ that could stop the chainsaws

英国の精密発酵スタートアップSun Bear Biofutureが、業界標準の10％未満のコストで構築した環境で、ココアバター代替品の生産に成功したと発表しました。来年、化粧品会社との提携による製品化を計画しています。

UK biotech firm Sun Bear Biofuture has completed the first run of its yeast-derived cocoa butter alternative in a setup that costs less than 10% of the industry standard. British startup Sun Bear Biofuture is out to prove that precision fermentation can be scaled up cost-effectively. It has completed the first production run of its yeast-based alternative to cocoa butter, which it plans to launch next year via a cosmetics partnership. The fermentation process was carried out in a €25,000 custom-built pilot plant, representing less than 10% of the average setup costs. The automated, end-to-end facility has a production capacity of dozens of kgs per month, which the firm will use to supply food and cosmetics companies with more resilient, planet-friendly lipids. “Proving our low-capex expansion plan was a key goal for this year, and we’ve smashed it,” said Ben Wilding, co-founder and CEO of Sun Bear Biofuture. “The scope to meet customer demand for stable supply chains by producing our cocoa butter and oil range locally, whilst dramatically reducing the impact the industry has on the planet, is hugely exciting,” he added. How Sun Bear Biofuture is slashing precision fermentation costs Founded in 2022, Sun Bear Biofuture has been...

Un grupo de alumnas de Secundaria expone una investigación sobre el impacto de los plásticos en el crecimiento vegetal en un encuentro científico inclusivo y sostenible que acerca la ciencia real al alumnado Leer

On the sidelines of COP30, government representatives and industry leaders today announced the launch of the Biofuture Platform Declaration on Sustainable Chemicals and Materials, a landmark international...

Join Dr. Connor Glass, CEO of Phantom Neuro, as he presents groundbreaking advancements in human-machine interfaces at BioFuture 2025 in NYC.

Austin-Headquartered Neurotech Maverick Reflects Upon Industry, Company Growth NEW YORK, Oct. 8, 2025 /PRNewswire/ -- Dr. Connor Glass, CEO and Founder of Phantom Neuro, the company delivering breakthrough advancements in human-machine interface, will be speaking on the mainstage of this...

New York, New York--(Newsfile Corp. - September 19, 2025) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced that it has been invited to participate in the "Beyond the Cure: The Brave New World of Revolutionary Cancer Therapeutics" Spotlight Panel at BioFuture 2025 taking place at Cure in New York City on October 13, 2025 at 11:00am EDT. A virtual partnering option...

Policymakers and industries in more than 20 countries have signed on to a “Biofuture Platform” that would use biofuels, bioplastics and biomaterials as an alternative to fossil fuels. The consequences for land, food production, ecosystems and human rights would be dire.

Policymakers and industries in more than 20 countries have signed on to a “Biofuture Platform” that would use biofuels, bioplastics and biomaterials as an alternative to fossil fuels. The consequences for land, food production, ecosystems and human rights would be dire.